Cytochrome P450 Enzymes: |
---|
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 2.600E-10 | 9.436E-07 | CYP1A2, CYP2C19, CYP2C9, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0070989; oxidative demethylation | 2.600E-10 | 9.436E-07 | CYP1A2, CYP2C9, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0006805; xenobiotic metabolic process | 5.282E-08 | 5.001E-05 | CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 8.120E-08 | 6.801E-05 | CYP1A2, CYP2C19, CYP2C9 |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 8.942E-07 | 6.281E-04 | CYP1A2, CYP2C19, CYP2C9 |
BP | GO:0008152; metabolic process | GO:0006706; steroid catabolic process | 1.743E-06 | 1.150E-03 | CYP19A1, CYP1A2, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0009822; alkaloid catabolic process | 2.459E-06 | 1.487E-03 | CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 4.759E-06 | 2.801E-03 | CA12, CA7, CA9 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 8.786E-06 | 4.666E-03 | CA12, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 2.294E-15 | 4.995E-11 | CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4 |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa00140 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.831E-05 | 8.469E-05 | CYP1A2; CYP3A4; CYP19A1 |
hsa00232 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.492E-03 | 1.279E-02 | CYP1A2 |
hsa00590 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.401E-03 | 4.713E-03 | CYP2C9; CYP2C19 |
hsa00591 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.075E-08 | 1.989E-07 | CYP2C9; CYP1A2; CYP3A4; CYP2C19 |
hsa00830 | Retinol metabolism_Homo sapiens_hsa00830 | 3.004E-07 | 3.558E-06 | CYP2C9; CYP1A2; ALDH1A1; CYP3A4 |
hsa00910 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.130E-07 | 3.558E-06 | CA12; CA7; CA9 |
hsa00980 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 4.808E-07 | 3.558E-06 | CYP2C9; CYP2D6; CYP1A2; CYP3A4 |
hsa00982 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.489E-09 | 1.291E-07 | CYP2C9; CYP2D6; CYP1A2; CYP3A4; CYP2C19 |
hsa01100 | Metabolic pathways_Homo sapiens_hsa01100 | 5.303E-06 | 2.803E-05 | CYP2C9; ODC1; CYP1A2; ALDH1A1; CYP2C19; CYP3A4; CYP19A1; HSD17B10 |
hsa04210 | Apoptosis_Homo sapiens_hsa04210 | 6.916E-03 | 1.828E-02 | CASP7; LMNA |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Burns and burn infection | A00-B99 | ODC1 |
A00-B99: Certain infectious and parasitic diseases | Bacterial infections | A00-B99 | CYP2C9 |
A00-B99: Certain infectious and parasitic diseases | African trypanosomiasis | B56 | ODC1 |
A00-B99: Certain infectious and parasitic diseases | Malaria | B54 | CYP2D6 |
C00-D49: Neoplasms | Hormonally-responsive breast cancer | C50 | CYP19A1 |
C00-D49: Neoplasms | Solid tumours | C00-D48 | CA9 |
C00-D49: Neoplasms | Cancer | C00-C96 | CA9 |
C00-D49: Neoplasms | Bladder cancer | C67 | CYP19A1 |
C00-D49: Neoplasms | Lymphoma | C81-C86 | CA9 |
C00-D49: Neoplasms | Breast cancer | C50 | CA9; CYP19A1 |